Amino-pyridine-containing spleen tyrosine kinase (SYK) inhibitors
AssigneeMerck Sharp & Dohme Corp.
InventorsEric Thomas Romeo, Michelle R. Machacek, Benjamin Wesley Trotter, Thomas Allen Miller, Brian Michael Andresen, Neville John Anthony, Brandon M. Taoka, Yuan Liu
Life of this patent
Estimating the term…
Abstract
The invention provides certain amino-pyridine-containing compounds of the Formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, and n are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by Spleen Tyrosine Kinase (Syk) kinase.
Claims38
A compound of the Formula (I)
- or a pharmaceutically acceptable salt thereof, wherein
- R1 is selected from the group consisting of:
- (i) —C1-C3 alkyl;
- (ii) fluoroalkyl;
- (iii) —CH2OR1a,
- wherein R1a is selected from the group consisting of H and C1-C6 alkyl;
- (iv) —N(R1b)2,
- wherein each occurrence of R1b is selected from the group consisting of H and C1-C3 alkyl, or two R1b together with the N atom to which they are attached form a group of the formula
- wherein r is 1, 2, 3, or 4;
- (v) —O—(C1-C3 alkyl);
- (vi) —N(H)C(O)—(C1-C3 alkyl);
- (vii) halo;
- (viii) H;
- and
- (ix) morpholinyl;
- R2 is —OH, —O—(C1-C3 alkyl), —N(R2a)2, —N(R2a)C(O)_R2b;
- or —F;
- wherein each occurrence of R2a is selected from the group consisting of H and C1-C3 alkyl;
- and
- R2b is C1-C6 alkyl;
- R3 is —CO2R3a, —CH2CO2R3a, —CH2CH2CO2R3a, tetrazole, —C(O)N(R3b)2, —CH2OH, H, halo, —OH C1-C6 alkyl, —O—(C1-C3 alkyl), —N(R3b)2, —CN, —C(O)N(H)S(O)2R3c, —C(O)—N(H)(R3d), —C(O)N(H)C(O)R3a, —P(O)(OR3b)2, or —B(OH)2;
- wherein R3a is selected from the group consisting of H and C1-C6 alkyl;
- wherein each R3b is independently selected from the group consisting of H and C1-C3 alkyl;
- wherein R3c is selected from the group consisting of C1-C3 alkyl, C1-C3 fluoroalkyl, C3-C6 cycloalkyl, and phenyl, wherein said phenyl is unsubstituted or substituted with one or two C1-C3 alkyl;
- wherein R3d is selected from the group consisting of —CN, —O—(C1-C3 alkyl), and tetrazole;
- R4 is —CO2R4a, —CH2CO2R4a, —CH2CH2CO2R4a, tetrazole, —C(O)N(R4b)2, —CH2OH, H, halo, —OH, C1-C6 alkyl, —O—(C1-C3 alkyl), —N(R4b)2, —CN, —C(O)N(H)S(O)2R4c, —C(O)—N(H)(R4d), —C(O)N(H)C(O)R4a, —P(O)(OR4b)2, or —B(OH)2;
- wherein R4a is selected from the group consisting of H and C1-C6 alkyl;
- wherein each R4b is independently selected from the group consisting of H and C1-C3 alkyl;
- wherein R4c is selected from the group consisting of C1-C3 alkyl, C1-C3 fluoroalkyl, C3-C6 cycloalkyl, and phenyl, wherein said phenyl is unsubstituted or substituted with one or two C1-C3 alkyl;
- wherein R4d is selected from the group consisting of —CN, —O—(C1-C3 alkyl), and tetrazole;
- R5 is —CO2R5a, —CH2CO2R5a, —CH2CH2CO2R5a, tetrazole, —C(O)N(R5b)2, —CH2OH, H, halo, —OH, C1-C6 alkyl, —O—(C1-C3 alkyl), —N(R5b)2, —CN, —C(O)N(H)S(O)2R5c, —C(O)—N(H)(R5d), —C(O)N(H)C(O)R5a, —P(O)(OR5b)2, or —B(OH)2;
- wherein R5a is selected from the group consisting of H and C1-C6 alkyl;
- wherein each R5b is independently selected from the group consisting of H and C1-C3 alkyl;
- wherein R5c is selected from the group consisting of C1-C3 alkyl, C1-C3 fluoroalkyl, C3-C6 cycloalkyl, and phenyl, wherein said phenyl is unsubstituted or substituted with one or two C1-C3 alkyl;
- wherein R5d is selected from the group consisting of —CN, —O—(C1-C3 alkyl), and tetrazole;
- R6 is selected from the group consisting of:
- (i) C1-C6 alkyl;
- (ii) C1-C3 fluoroalkyl;
- (iii) —O—(C1-C6 alkyl);
- (iv) —O—(C1-C3 fluoroalkyl);
- (v) —R6a, wherein R6a is selected from the group consisting of:
- (a) C3-C6 cycloalkyl;
- (b) a group of the formula
- wherein m is 1, 2, 3, or 4;
- (c) a group of the formula
- where R6a1 is H, C1-C3 alkyl, or —CH2CH2NH2;
- and
- (d) a 5- to 6-membered heteroaryl containing 1 to 3 heteroatoms selected from the group consisting of N, O, and S;
- wherein R6a is unsubstituted or substituted with 1 to 3 R6a2 moieties selected from the group consisting of halo and C1-C3 alkyl;
- (vi) —O—R6b,
- wherein R6b is selected from the group consisting of:
- (a) C3-C6 cycloalkyl;
- and
- (b) a group of the formula
- wherein p is 0, 1, or 2, and q is 1, 2, or 3;
- wherein R6b is unsubstituted or substituted with 1 to 2 R6b1 moieties selected from the group consisting of fluoro and C1-C3 alkyl;
- (vii) —N(R6c)2, wherein each occurrence of R6c is selected from the group consisting of H and C1-C3 alkyl;
- (viii) —N(H)C(O)—(C1-C3 alkyl);
- (ix) —N(H)C(O)O—(C1-C3 alkyl);
- (x) —NHC(O)—N(R6d)2, wherein each R6d is H or C1-C3 alkyl;
- (xi) halo;
- and
- (xii) H;
- R7 is H or halo;
- R8 is H or halo;
- R9 is H or halo;
- and
- n is 0, 1, or 2.
A compound of the Formula IA or a pharmaceutically acceptable salt thereof
- wherein
- R4 is —CO2R4a, —C(O)NH2, or —CH2OH;
- wherein R4a is selected from the group consisting of H and CH3;
- R5 is H or fluoro;
- R6 is selected from the group consisting of:
- (i) C1-C4 alkyl;
- (ii) C1-C3 fluoroalkyl;
- (iii) —O—(C1-C6 alkyl);
- (iv) —R6a, wherein R6a is selected from the group consisting of:
- (a) C3-C6 cycloalkyl,
- (b) a group of the formula
- where R6a1 is H or —CH2CH2NH2;
- and
- (c) a 5-membered heteroaryl containing 1 to 3 heteroatoms selected from the group consisting of N, O, and S;
- wherein R6a is unsubstituted or substituted with 1 to 3 R6a2 moieties selected from the group consisting of halo and C1-C3 alkyl;
- (v) —O—R6b;
- and
- wherein R6b is selected from the group consisting of:
- (a) C3-C6 cycloalkyl;
- and
- (b) a group of the formula
- wherein p is 1 or 2, and q is 1 or 2;
- wherein R6b is unsubstituted;
- and
- R7 is H or halo.
A compound which is (5R)-5-hydroxy-5-[5-(4-methyl-6-{[4-(piperazin-1-yl)pyridin-2-yl]amino}pyridin-2-yl)-1,3-thiazol-2-yl]-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid or a pharmaceutically acceptable salt thereof.
A compound which is (5R)-5-hydroxy-5-[5-(4-methyl-6-{[4-(trifluoromethyl)pyridin-2-yl]amino}pyridin-2-yl)-1,3-thiazol-2-yl]-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid or a pharmaceutically acceptable salt thereof.
A compound which is (5R)-3-fluoro-5-hydroxy-5-[5-(4-methyl-6-{[4-(trifluoromethyl)pyridin-2-yl]amino}pyridin-2-yl)-1,3-thiazol-2-yl]-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid or a pharmaceutically acceptable salt thereof.
A compound which is (5R)-5-{5-[4-(acetylamino)-6-{[4-(trifluoromethyl)pyridin-2-yl]amino}pyridin-2-yl]-1,3-thiazol-2-yl}-5-hydroxy-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid or a pharmaceutically acceptable salt thereof.
A compound which is (1R)-1-hydroxy-1-[5-(4-methyl-6-{[4-(trifluoromethyl)pyridin-2-yl]amino}pyridin-2-yl)-1,3-thiazol-2-yl]-2,3-dihydro-1H-indene-4-carboxylic acid or a pharmaceutically acceptable salt thereof.
A compound which is (5R)-5-hydroxy-5-[5-(4-methyl-6-{[4-(trifluoromethyl)pyridin-2-yl]amino}pyridin-2-yl)-1,3-thiazol-2-yl]-5,6,7,8-tetrahydronaphthalene-2-carbonitrile or a pharmaceutically acceptable salt thereof.
A compound which is (5R)-5-hydroxy-5-[5-(4-methyl-6-{[4-(piperazin-1-yl)pyridin-2-yl]amino}pyridin-2-yl)-1,3-thiazol-2-yl]-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid.
A compound which is (5R)-5-hydroxy-5-[5-(4-methyl-6-{[4-(trifluoromethyl)pyridin-2-yl]amino}pyridin-2-yl)-1,3-thiazol-2-yl]-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid.
A compound which is (5R)-3-fluoro-5-hydroxy-5-[5-(4-methyl-6-{[4-(trifluoromethyl)pyridin-2-yl]amino}pyridin-2-yl)-1,3-thiazol-2-yl]-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid.
A compound which is (5R)-5-{5-[4-(acetylamino)-6-{[4-(trifluoromethyl)pyridin-2-yl]amino}pyridin-2-yl]-1,3-thiazol-2-yl}-5-hydroxy-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid.
A compound which is (1R)-1-hydroxy-1-[5-(4-methyl-6-{[4-(trifluoromethyl)pyridin-2-yl]amino}pyridin-2-yl)-1,3-thiazol-2-yl]-2,3-dihydro-1H-indene-4-carboxylic acid.
A compound which is (5R)-5-hydroxy-5-[5-(4-methyl-6-{[4-(trifluoromethyl)pyridin-2-yl]amino}pyridin-2-yl)-1,3-thiazol-2-yl]-5,6,7,8-tetrahydronaphthalene-2-carbonitrile.
Dependencies are inferred from the claim text.